Search
Search Results
##search.searchResults.foundPlural##
-
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
2001PDF: 843HTML: 231 -
Pseudo-differentiation syndrome
1396PDF: 676HTML: 10853Figure 1: peripheral blood showing myeloblasts with auer rods: 123Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 108Figure 3: CXR showing pulmonary infiltartes with consolidation: 138Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 120Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 119 -
WHAT ARE FUNGAL INFECTIONS?
4256PDF: 2427HTML: 27637de Pauw: 245 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1528PDF: 1091HTML: 225 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7882PDF: 732HTML: 222 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1565PDF: 893HTML: 989figures: 193table 1: 193table2: 190table3: 193 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2232PDF: 1214HTML: 3880 -
Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major
730PDF: 571HTML: 170 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1228PDF: 957HTML: 467 -
How I treat acute and persistent sickle cell pain
1986PDF: 1127HTML: 492 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1806PDF: 1185HTML: 256 -
FIRST TUNISIAN CLUSTER ADMISSIONS OF CRITICALLY ILL PATIENTS WITH MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) : Multisystem inflammatory syndrome in children (MIS-C)
1366PDF: 527HTML: 197 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1463PDF: 736HTML: 4567Figure 1: Chest radiograph: 219Figure 2: Flow cytometer analysis of pleural fluid: 189 -
HOMOZYGOUS DELETION ALFA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, TWO GENETIC FACTORS PREDICTIVE THE REDUCTION OF MORBIDITY AND MORTALITY DURING PREGNANCY IN SICKLE CELL PATIENTS . A REPORT FROM DEMOCRATIC REPUBLIC OF CONGO ALPHA THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN REDUCE MORBIDITY DURING PREGNANCY IN SICKLE CELL PATIENTS
10088PDF: 999HTML: 230 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1448PDF: 1335HTML: 106 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1803PDF: 586HTML: 302 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2576PDF: 857HTML: 8914Efremov 1: 238Efremov 2: 204 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1495PDF: 894HTML: 322 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1210PDF: 749Html: 104 -
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1686PDF: 598HTML: 420







